The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy

Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3

(2016) Ge Li-Sha et al.   LIFE SCIENCES

Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

(2015) Ge Li-Sha et al.   Scientific Reports

Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis

(2013) Yue-Chun Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography

(2012) B. O Hartaigh et al.   EUROPEAN HEART JOURNAL

Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure

(2012) Peter Moritz Becher et al.   HYPERTENSION

Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study

(2012) Alberto Dominguez-Rodriguez et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis

(2012) Li Yue-Chun et al.   PLoS One

MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart

(2010) John M. Streicher et al.   CIRCULATION RESEARCH

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration

(2010) Thomas Walcher et al.   MEDIATORS OF INFLAMMATION

Dominant-negative p38α mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus

(2009) Rajarajan A. Thandavarayan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis — ongoing inflammation and an imbalance of the matrix degrading system

(2009) Susanne Rutschow et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Immunomodulation and matrix metalloproteinases in viral myocarditis

(2009) Dirk Westermann et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Heart Rate as a Risk Factor for Cardiovascular Disease

(2009) Christine Perret-Guillaume et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

(2008) G Heusch   BRITISH JOURNAL OF PHARMACOLOGY

Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

(2008) Florian Custodis et al.   CIRCULATION

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET